CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- UPLOAD Other SEC-generated Letter
- 8-K Event Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Other events
- 4 Insider Changes in Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- DEF 14A Proxy Proxy Statement
- PRER14A Other PRER14A
- SC 13D Stake Beneficial Ownership Report
- PRER14A Other PRER14A
- UPLOAD Other SEC-generated Letter
- CT ORDER Other Confidential Order
- S-3/A Offering Registration Statement
- S-3 Offering Registration Statement
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 8-K Event Exhibits
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 57 of 74 · 1,467 filings